Aller au contenu principal
Profil bibliographique

Zecong Xiao

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

67Publications signalées
3505Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Nanoplatforms for cancer theranosticsImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersNanoparticle-Based Drug DeliveryWound Healing and Treatments

Les publications récentes

Accès ouvert 2025 article OpenAlex

αPD-1-conjugated acid-cleavable nanodrugs overcomes cellular immunotherapy barriers in pancreatic tumors

Zhengkai Gan, Jing Huang, Minzhao Lin, Shaohui Deng et autres

Overcoming barriers in solid tumor immunotherapy remains challenging, with adoptive T cell therapies limited by antigen loss, poor tumor infiltration, and T cell exhaustion. Here, we present a nanoengineered tumor-infiltrating lymphocyte (TIL) therapy using anti-PD-1 antibody (αPD-1)-conjugated ZIF-8 nanoparticles to effectively suppress …

us, cn (code pays fourni par la source)

5 citations Nature Communications
Accès ouvert 2025 article OpenAlex

Tirzepatide retention in iWAT with mesoporous polydopamine encapsulation enhances weight loss through leptin receptor signaling

Lin Mi, Tan Li, Xiaoxin Xiang, Na Xiong et autres

INTRODUCTION: Tirzepatide (TZP), a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, has been showing superior benefits in weight loss and glucose lowering in patients with obesity, while the tissue-specific mechanisms of TZP as well as its side effects remain to be …

cn, us (code pays fourni par la source)

2 citations Journal of Advanced Research
2025 article OpenAlex

Engineering Mesenchymal Stem Cells with Antioxidant Catalase‐Loaded Metal–Organic Frameworks for Targeted Spinal Cord Injury Therapy

Shiyun Xian, Shuguang Yang, Zhouzhou Liao, Yujie Jiang et autres

Abstract Spinal cord injury (SCI) therapy is challenging because of the associated irreversible neurological deficits. These deficits are caused by primary damage and secondary pathological processes such as oxidative stress and inflammation. Although mesenchymal stem cells (MSC) demonstrate potential in SCI treatment …

cn (code pays fourni par la source)

9 citations Advanced Functional Materials
Accès ouvert 2025 article OpenAlex

A PD‐L1 siRNA‐Loaded Boron Nanoparticle for Targeted Cancer Radiotherapy and Immunotherapy

Shaohui Deng, Lijun Hu, Guo Chen, Jujian Ye et autres

Abstract Although the combination of radiotherapy and immunotherapy is regarded as a promising clinical treatment strategy, numerous clinical trials have failed to demonstrate synergistic effects. One of the key reasons is that conventional radiotherapies inevitably damage intratumoral effector immune cells. Boron Neutron …

cn, us (code pays fourni par la source)

50 citations Advanced Materials

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.